S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(0.12%) $82.73
Gas
(1.13%) $2.05
Gold
(-0.47%) $2 346.60
Silver
(-0.92%) $27.41
Platinum
(-0.24%) $959.20
USD/EUR
(-0.19%) $0.933
USD/NOK
(-0.30%) $10.99
USD/GBP
(-0.53%) $0.796
USD/RUB
(1.56%) $93.31

Sanntidsoppdatering for First Trust Heitman [PRME]

Børs: NYSE Sektor: Healthcare Industri: Biotechnology
BUY
100.00%
return 6.79%
SELL
50.00%
return 3.93%
Sist oppdatert29 apr 2024 @ 22:00

9.83% $ 4.86

KJøP 108101 min ago

@ $6.86

Utstedt: 14 feb 2024 @ 21:49


Avkastning: -29.15%


Forrige signal: feb 14 - 15:30


Forrige signal: Selg


Avkastning: 2.01 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence...

Stats
Dagens volum 1.27M
Gjennomsnittsvolum 727 290
Markedsverdi 582.90M
EPS $0 ( 2024-03-14 )
Neste inntjeningsdato ( $-0.470 ) 2024-05-09
Last Dividend $0.800 ( 2019-09-10 )
Next Dividend $0 ( N/A )
P/E -2.23
ATR14 $0.00900 (0.19%)
Insider Trading
Date Person Action Amount type
2024-02-29 Marrazzo Jeffrey D Buy 250 000 Stock Option (right to buy)
2024-02-20 Gv 2023 Gp, L.l.c. Buy 0 Common Stock
2024-02-25 Gottesdiener Keith Michael Buy 100 000 Stock Option (right to buy)
2024-02-21 Brudnick Richard Buy 135 747 Stock Option (right to buy)
2024-02-21 Duffield Jeremy Buy 180 995 Stock Option (right to buy)
INSIDER POWER
34.78
Last 97 transactions
Buy: 38 299 882 | Sell: 27 394 093

Volum Korrelasjon

Lang: -0.04 (neutral)
Kort: 0.25 (neutral)
Signal:(44.472) Neutral

First Trust Heitman Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

First Trust Heitman Korrelasjon - Valuta/Råvare

The country flag 0.78
( moderate )
The country flag 0.79
( moderate )
The country flag 0.00
( neutral )
The country flag -0.27
( neutral )
The country flag 0.11
( neutral )
The country flag -0.82
( strong negative )

First Trust Heitman Økonomi

Annual 2023
Omsetning: $0
Bruttogevinst: $-4.65M (0.00 %)
EPS: $-2.18
FY 2023
Omsetning: $0
Bruttogevinst: $-4.65M (0.00 %)
EPS: $-2.18
FY 2022
Omsetning: $5.21M
Bruttogevinst: $-6.80M (-130.60 %)
EPS: $-1.250
FY 2021
Omsetning: $0.00
Bruttogevinst: $0.00 (0.00 %)
EPS: $-2.55

Financial Reports:

No articles found.

First Trust Heitman Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

First Trust Heitman Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.0900 2015-12-23
Last Dividend $0.800 2019-09-10
Next Dividend $0 N/A
Payout Date 2019-09-12
Next Payout Date N/A
# dividends 15 --
Total Paid Out $3.83 --
Avg. Dividend % Per Year 0.00% --
Score 1.65 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-21)
$0 Estimate 0.00 %
Dividend Stability
0.09 Very Bad
Dividend Score
1.65
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
NCZ Dividend Royal 2024-02-09 Monthly 22 7.79% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-1.0221.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9371.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.530.8002.331.864[1 - 3]
quickRatioTTM2.160.8002.021.617[0.8 - 2.5]
cashRatioTTM0.7371.5007.0210.00[0.2 - 2]
debtRatioTTM0.0703-1.5008.83-10.00[0 - 0.6]
interestCoverageTTM440.771.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
freeCashFlowPerShareTTM-1.7882.00-0.894-1.788[0 - 20]
debtEquityRatioTTM0.102-1.5009.59-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-12.131.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.156

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.171.000-0.3210[1 - 100]
returnOnEquityTTM-0.9372.50-7.41-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.7882.00-0.596-1.788[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.06241.500-2.920[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.952

First Trust Heitman

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.